Binge-Eating Disorder
A disorder associated with three or more of the following: eating until feeling uncomfortably full; eating large amounts of food when not physically hungry; eating much more rapidly than normal; eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months. The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994)
Drugs by status
Approved for this indication (1)
Phase 4 trials (3)
Phase 3 trials (12)
Phase 2 trials (15)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (13)
- Takeda
- Alkermes
- National Institute of Mental Health (NIMH)
- Multidisciplinary Association for Psychedelic Studies
- University of Toronto
- University of Virginia
- Columbia University
- University of Chicago
- MAPS Public Benefit Corporation
- University of North Carolina at Chapel Hill
- Brain & Behavior Research Foundation
- Foundation of Hope, North Carolina
- Ontario Mental Health Foundation
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (3)